Correlation of percentage changes in platelet counts with recurrence rate following radical nephrectomy

Indian Journal of Urology

Volumn 26, Issue 2, 2010, Pages 183-187

  Patel, A ^a   Bhavan, R ^a   Somani, B ^a   Nabi, G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Platelets; radical nephrectomy; renal cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; NEPHRECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

EID: 77954985355     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.65383     Document Type: Article

References (19)

1. Bensalah K, Leray E, Fergelot P, Rioux-Leclercq N, Tostain J, Guillé F, et al. Prognostic value of thrombocytosis in renal cell carcinoma. J Urol 2006;175:859-863 (Pubitemid 43199997)
2. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr Opin Urol 2007;17:303-308
3. Symbas NP, Townsend MF, El-Galley R, Keane TE, Graham SD, Petros JA. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 2000;86:203-207
4. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-663
5. Levin J, conley CL. Thrombocytosis associated with malignant disease. Arch Intern Med 1964;114:497-500.
6. O'Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 2002;168:1378-1380
7. Verheul HM, Pinedo HM. The importance of platelet counts and their contents in cancer. Clin Cancer Res 2003;9:3219-3221
8. Suppiah R, Shaheen PE, Elson P, Misbah SA, Wood L, Motzer RJ, et al. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 2006;107:1793-1800 (Pubitemid 44582948)
9. Ito K, Asano T, Yoshii H, Satoh A, Sumitomo M, Hayakawa M. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma. Int J Urol 2006;13:1365-1370
10. Daly ME, Makris A, Reed M, Lewis CE. Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment? J Natl Cancer Inst 2003;95:1660-1673
11. Jacobsen J, Grankvist K, Rasmuson T, Ljungberg B. Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma. Eur J Cancer Prev 2002;11:245-252
12. Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA, Gasic GJ. Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res 1987;47:4130-4133
13. Schuler M, Peschel C, Schneller F, Fichtner J, Färber L, Huber C, et al. Immunomodulatory and hematopoietic effects of recombinant human interleukin-6 in patients with advanced renal cell cancer. J Interferon Cytokine Res 1996;16:903-910
14. Hollen CW, Henthorn J, Koziol JA, Burstein SA. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 1991;79:286-290
15. Göǧüş C, Baltaci S, Filiz E, Elhan A, Bedük Y. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma. Urology 2004;63:447-450
16. Golshayan AR, Brick AJ, Choueiri TK. Predicting outcome to VEGFtargeted therapy in metastatic clear-cell renal cell carcinoma: Data from recent studies. Future Oncol 2008;4:85-92.
17. Lam S, Leppert JT, Yu H. Expression of the vascular endothelial growth factor family in tumor dissemination and disease free survival in clear cell renal cell carcinoma. J Clin Oncol 2005;23:387.
18. Golshayan A, Chouriei TK, Elson P. Clinical factors associated with outcome in metastatic renal cell carcinoma patients treated with VEGF-targeted therapy. J Clin Oncol 2007;25:5046.
19. Lane BR, Kattan MW. Predicting outcomes in renal cell carcinoma. Curr Opin Urol 2005;15:289-297